Aplastic anemia: immunosuppressive therapy in 2010
Acquired aplastic anemia (AA) is the typical bone marrow failure syndrome characterized by an empty bone marrow; an immune-mediated pathophysiology has been demonstrated by experimental works as well as by clinical observations. Immunusuppressive therapy (IST) is a key treatment strategy for aplasti...
Saved in:
Main Authors: | Antonio M. Risitano (Author), Fabiana Perna (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2011-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcome of immunosuppressive therapy in children with acquired aplastic anemia
by: Alaka Das, et al.
Published: (2024) -
Outcome of immunosuppressive therapy in children with acquired aplastic anemia
by: Alaka Das, et al.
Published: (2024) -
Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
by: Yufei Zhao, et al.
Published: (2023) -
Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia
by: Chen HF, et al.
Published: (2014) -
Response to the second cycle of immunosuppressive therapy (antithymocyte globulin)in children with aplastic anemia
by: Rupamon Nongbet, et al.
Published: (2022)